MartinJanBergmanMD

PubMed

• 2 citations
  Clinical and Economic Benefit of Achieving Disease Control in Psoriatic Arthritis and Ankylosing Spondylitis: A Retrospective Analysis from the OM1 Registry.
  Martin J Bergman, Patrick Zueger, Jayeshkumar Patel, Christopher D Saffore, Ia Topuria, Cristi Cavanaugh, Siran Fang, Jerry Clewell, Alexis Ogdie> ;Rheumatology and Therapy. 2023 Feb 1
• Safety of jakinibs: lessons from ORAL Surveillance.
  Marwan Bukhari, Martin Bergman, Jon T Giles, Carlos Lozada, John Cush, Kunihiro Yamaoka, Catriona McKay, Arthur Kavanaugh> ;Rheumatology. 2022 Nov 2
• Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with Rheumatoid Arthritis Treated with Long-Term Upadacitinib Therapy in Five Randomized Controlled Tri...
  Martin Bergman, Maya H Buch, Yoshiya Tanaka, Gustavo Citera, Sami Bahlas, Ernest Wong, Yanna Song, Patrick Zueger, Mira Ali, Vibeke Strand> ;Rheumatology and Therapy. 2022 Dec 1
• 3 citations
  Baseline Disease Activity Predicts Achievement of cDAPSA Treatment Targets With Apremilast: Phase III Results in DMARD-naïve Patients With Psoriatic Arthritis.
  Philip J Mease, Arthur Kavanaugh, Alexis Ogdie, Alvin F Wells, Martin Bergman, Dafna D Gladman, Sven Richter, Lichen Teng, Shauna Jardon, Josef S Smolen> ;The Journal of Rheumatology. 2022 Jul 1
• 4 citations
  The effect of secukinumab on patient-reported outcomes in patients with active psoriatic arthritis in a randomised phase 3 trial.
  Gladman, D., Coates, L., Sherif, B., Hur, P., Parikh, B., Gilloteau, I., Strand, V., Kaeley, G., Bergman, M., Mease, P.> ;The Lancet. Rheumatology. 2022 Mar 1
• 5 citations
  Guided therapy selection in rheumatoid arthritis using a molecular signature response classifier: an assessment of budget impact and clinical utility.
  Christopher Arnell, Martin J. Bergman, Dhiman Basu, James T. Kenney, Johanna B Withers, Jennifer Logan, Jeraldine Lim Harashima, Erin Connolly-Strong> ;Journal of Managed Care & Specialty Pharmacy. 2021 Oct 20
• 1 citations
  Should Quantitative Measures and Management of Rheumatoid Arthritis Include More Than Control of Inflammatory Activity
  Theodore Pincus, Martin J. Bergman, Yusuf Yazici> ;The Journal of Rheumatology. 2021 Oct 15
• 3 citations
  Economic Benefit from Improvements in Quality of Life with Upadacitinib: Comparisons with Tofacitinib and Methotrexate in Patients with Rheumatoid Arthritis
  Martin J. Bergman, Namita Tundia, Min Yang, Eli Orvis, Jerry Clewell, Arielle G. Bensimon> ;Advances in Therapy. 2021 Oct 12
• 4 citations
  Healthcare Resource Use in Patients with Immune-Mediated Conditions Treated with Targeted Immunomodulators During COVID-19 Pandemic: A Retrospective Claims Analysis.
  Martin J. Bergman, Christopher D. Saffore, Katherine J. Kim, Pankaj Patel, Vishvas Garg, Si Xuan, Haley B. Naik> ;Advances in Therapy. 2021 Sep 13
• 5 citations
  Healthcare Costs of Not Achieving Remission in Patients with Rheumatoid Arthritis in the United States: A Retrospective Cohort Study
  Martin J. Bergman, L. Zhou, Pankaj Patel, Ruta Sawant, Jerry Clewell, Namita Tundia> ;Advances in Therapy. 2021 Apr 9
• Use of Precision Medicine to Guide Treatment of Patients With Rheumatoid Arthritis: Comment on the Article by Tao et al.
  Stanley Cohen, Theodore Mellors, Martin J. Bergman> ;Arthritis & Rheumatology. 2021 Mar 1
• 16 citations
  Upadacitinib improves patient-reported outcomes vs placebo or adalimumab in patients with rheumatoid arthritis: results from SELECT-COMPARE.
  Vibeke Strand, Namita Tundia, Martin J. Bergman, A. Ostor, Patrick Durez, In-Ho Song, Jeffrey Enejosa, Casey Schlacher, Yan Song, Roy Fleischmann> ;Rheumatology. 2021 Feb 16
• 1 citations
  Comment on: 'It can't be zero!' Difficulties in completing patient global assessment in rheumatoid arthritis: a mixed methods study.
  Theodore Pincus, Kathryn A. Gibson, Yusuf Yazici, Martin J. Bergman, Juan Schmukler, Joel A. Block> ;Rheumatology. 2021 Jan 5
• 14 citations
  Upadacitinib monotherapy improves patient-reported outcomes in rheumatoid arthritis: results from SELECT-EARLY and SELECT-MONOTHERAPY
  Vibeke Strand, Namita Tundia, Alvin F. Wells, Maya H Buch, Sebastião Cezar Radominski, Heidi S. Camp, Alan Friedman, J. Suboticki, K. Dunlap, Debbie Goldschmidt, Marti...> ;Rheumatology. 2020 Dec 11
• 23 citations
  Evaluation of Adherence and Persistence Differences Between Adalimumab Citrate-Free and Citrate Formulations for Patients with Immune-Mediated Diseases in the United S...
  Martin J. Bergman, Pankaj Patel, Naijun Chen, Yonghua Jing, Christopher D. Saffore> ;Rheumatology and Therapy. 2021 Mar 1
• 10 citations
  Data-Driven Patient Clustering and Differential Clinical Outcomes in the Brigham and Women’s Rheumatoid Arthritis Sequential Study Registry
  Jeffrey R. Curtis, Michael E. Weinblatt, Kenneth G. Saag, Vivian P. Bykerk, Daniel E. Furst, Stefano Fiore, Gregory St John, Toshio Kimura, Shen Zheng, Clifton O. Bing...> ;Arthritis Care & Research. 2021 Apr 1
• 20 citations
  Brief Report: Adaptation of American College of Rheumatology Rheumatoid Arthritis Disease Activity and Functional Status Measures for Telehealth Visits.
  Bryant R. England, Claire E.H. Barber, Martin J. Bergman, Veena K. Ranganath, Lisa G. Suter, Kaleb Michaud> ;Arthritis Care & Research. 2020 Aug 19
• 14 citations
  Clinical Utility and Cost Savings in Predicting Inadequate Response to Anti-TNF Therapies in Rheumatoid Arthritis.
  Martin J. Bergman, Alan Kivitz, Dimitrios A. Pappas, Joel M. Kremer, Lixia Zhang, Anna Jeter, Johanna B. Withers> ;Rheumatology and Therapy. 2020 Aug 14
• 9 citations
  Disease activity measures at baseline predict structural damage progression: data from the randomized, controlled AMPLE and AVERT trials
  Edward C. Keystone, Harris A. Ahmad, Yusuf Yazici, Martin J. Bergman> ;Rheumatology. 2020 Aug 1
• 10 citations
  High impact of burnout on rheumatology practitioners
  Vivekanand Tiwari, Arthur Kavanaugh, George Martin, Martin J. Bergman> ;The Journal of Rheumatology. 2020 Apr 1
• 6 citations
  Authors' Reply: Comments on the 2019 Update of the American College of Rheumatology Recommended Rheumatoid Arthritis Disease Activity Measures.
  Bryant R. England, Benedict K. Tiong, Martin J. Bergman, Jeffrey R. Curtis, Salahuddin Kazi, Ted R. Mikuls, James R. O'Dell, Veena K. Ranganath, Alex Limanni, Lisa G. ...> ;Arthritis Care & Research. 2020 Jan 31
• 130 citations
  2019 Update of the American College of Rheumatology Recommended Rheumatoid Arthritis Disease Activity Measures
  Bryant R. England, Benedict K. Tiong, Martin J. Bergman, Jeffrey R. Curtis, Salahuddin Kazi, Ted R. Mikuls, James R. O'Dell, Veena K. Ranganath, Alex Limanni, Lisa G. ...> ;Arthritis Care & Research. 2019 Dec 1
• 18 citations
  Osteoarthritis is as severe as rheumatoid arthritis: evidence over 40 years according to the same measure in each disease.
  Theodore Pincus, Isabelle Castrejon, Yusuf Yazici, Kathryn A. Gibson, Martin J. Bergman, Joel A. Block> ;Clinical and Experimental Rheumatology. 2019 Sep 1
• 4 citations
  Cost per response for abatacept versus adalimumab in patients with seropositive, erosive early rheumatoid arthritis in the US, Germany, Spain, and Canada
  Jason Foo, Chaienna Morel, Martin J. Bergman, Christoph Baerwald, José Manuel Rodriguez-Heredia, Alexander Marshall, Carlos Polanco-Sanchez, Roelien Postema> ;Rheumatology International. 2019 Jun 25
• 13 citations
  Minimal Clinically Important Improvement of Routine Assessment of Patient Index Data 3 in Rheumatoid Arthritis.
  Michael M Ward, Isabel Castrejon, Martin J Bergman, Maria I Alba, Lori C Guthrie, Theodore Pincus> ;The Journal of Rheumatology. 2019 Jan 1
• Join now to see all